ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study

被引：33

作者：

Iivanainen, Sanna ^{[1
]}

Alanko, Tuomo ^{[2
]}

Peltola, Katriina ^{[2
]}

Konkola, Teemu ^{[3
]}

Ekstroem, Jussi ^{[3
]}

Virtanen, Henri ^{[3
]}

Koivunen, Jussi P. ^{[1
]}

机构：

[1] Oulu Univ Hosp OYS, MRC Oulu, Dept Radiotherapy & Oncol, PB 22, Oulu 90029, Finland

[2] Docrates Canc Ctr, Helsinki, Finland

[3] Kaiku Hlth Oy, Helsinki, Finland

来源：

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 2019年 / 145卷 / 03期

关键词：

Patient-reported outcomes; Immune checkpoint inhibitor therapy; Symptoms; Real-world data; QUALITY-OF-LIFE; OPEN-LABEL PHASE-3; CELL LUNG-CANCER; REPORTED OUTCOMES; ONCOLOGY PRACTICE; ADVERSE EVENTS; PEMBROLIZUMAB; NIVOLUMAB; MULTICENTER; IPILIMUMAB;

D O I：

10.1007/s00432-018-02835-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose Patient-reported outcome (PRO) follow-up has been shown to improve quality of life (QoL) and survival of cancer patients receiving chemotherapy. Kaiku Health application is a web-based electronic PRO (ePRO) tool which is designed for follow-up of cancer patients receiving immune checkpoint inhibitors (ICI). Purpose of the current study is to investigate whether symptoms collected by Kaiku Health ePRO tool on cancer patients receiving immune checkpoint inhibitors (ICI) follows to symptoms reported in clinical trials and whether coupling of specific symptoms does occur. Methods We retrospectively collected data on symptom timing and severity, and QoL of patients followed with Kaiku Health IO module in two Finnish cancer centers between 2017 and 2018. Kaiku Health IO module consists of 18 adaptive questions, which assess the presence and severity of symptoms. Patients were requested (via e-mail) to fill online symptom questionnaires with 3-7day interval and QoL questionnaires (QLQ-C30) with 1-2 month interval. Results The IO module was used to follow 37 patients who had filled in total 559 symptom questionnaires. There was good adherence to ePRO follow-up with a median of 11 questionnaires filled per patient. The reported symptoms and their severity follow closely what has been seen in clinical trials investigating ICIs. Correlation analysis of the symptoms showed the strongest positive correlations between itching and rash; nausea and vomiting, decreased appetite, or stomach pain; cough and shortness of breath. Conclusions The results of the current study suggest that real-world symptom data collected through the ePRO application on cancer patients receiving ICI therapy aligns with the data from clinical trials. Correlations between different symptoms occur, which might reflect therapeutic efficiency, side effects, or tumor progression. These correlations should be further investigated with data coupled to clinical outcomes.

引用

页码：765 / 774

页数：10

共 46 条

[1] Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment [J].

Basch, Ethan ;

Deal, Allison M. ;

Dueck, Amylou C. ;

Scher, Howard I. ;

Kris, Mark G. ;

Hudis, Clifford ;

Schrag, Deborah .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (02) :197-198

[2] Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial [J].

Basch, Ethan ;

Deal, Allison M. ;

Kris, Mark G. ;

Scher, Howard I. ;

Hudis, Clifford A. ;

Sabbatini, Paul ;

Rogak, Lauren ;

Bennett, Antonia V. ;

Dueck, Amylou C. ;

Atkinson, Thomas M. ;

Chou, Joanne F. ;

Dulko, Dorothy ;

Sit, Laura ;

Barz, Allison ;

Novotny, Paul ;

Fruscione, Michael ;

Sloan, Jeff A. ;

Schrag, Deborah .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (06) :557-+

[3] Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes [J].

Basch, Ethan ;

Jia, Xiaoyu ;

Heller, Glenn ;

Barz, Allison ;

Sit, Laura ;

Fruscione, Michael ;

Appawu, Mark ;

Iasonos, Alexia ;

Atkinson, Thomas ;

Goldfarb, Shari ;

Culkin, Ann ;

Kris, Mark G. ;

Schrag, Deborah .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (23) :1624-1632

[4] Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma [J].

Bellmunt, J. ;

de Wit, R. ;

Vaughn, D. J. ;

Fradet, Y. ;

Lee, J. -L. ;

Fong, L. ;

Vogelzang, N. J. ;

Climent, M. A. ;

Petrylak, D. P. ;

Choueiri, T. K. ;

Necchi, A. ;

Gerritsen, W. ;

Gurney, H. ;

Quinn, D. I. ;

Culine, S. ;

Sternberg, C. N. ;

Mai, Y. ;

Poehlein, C. H. ;

Perini, R. F. ;

Bajorin, D. F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (11) :1015-1026

[5] Electronic patient-reported outcome systems in oncology clinical practice [J].

不详 .

CA-A CANCER JOURNAL FOR CLINICIANS, 2012, 62 (05) :336-347

[6]

Benze G, 2017, ANN PALLIAT MED

[7] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Borghaei, H. ;

Paz-Ares, L. ;

Horn, L. ;

Spigel, D. R. ;

Steins, M. ;

Ready, N. E. ;

Chow, L. Q. ;

Vokes, E. E. ;

Felip, E. ;

Holgado, E. ;

Barlesi, F. ;

Kohlhaeufl, M. ;

Arrieta, O. ;

Burgio, M. A. ;

Fayette, J. ;

Lena, H. ;

Poddubskaya, E. ;

Gerber, D. E. ;

Gettinger, S. N. ;

Rudin, C. M. ;

Rizvi, N. ;

Crino, L. ;

Blumenschein, G. R. ;

Antonia, S. J. ;

Dorange, C. ;

Harbison, C. T. ;

Finckenstein, F. Graf ;

Brahmer, J. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639

[8] Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial [J].

Brahmer, Julie R. ;

Rodriguez-Abreu, Delvys ;

Robinson, Andrew G. ;

Hui, Rina ;

Csoszi, Tibor ;

Fulop, Andrea ;

Gottfried, Maya ;

Peled, Nir ;

Tafreshi, Ali ;

Cuffe, Sinead ;

O'Brien, Mary ;

Rao, Suman ;

Hotta, Katsuyuki ;

Zhang, Jin ;

Lubiniecki, Gregory M. ;

Deitz, Anne C. ;

Rangwala, Reshma ;

Reck, Martin .

LANCET ONCOLOGY, 2017, 18 (12) :1600-1609

[9] Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper [J].

Champiat, S. ;

Lambotte, O. ;

Barreau, E. ;

Belkhir, R. ;

Berdelou, A. ;

Carbonnel, F. ;

Cauquil, C. ;

Chanson, P. ;

Collins, M. ;

Durrbach, A. ;

Ederhy, S. ;

Feuillet, S. ;

Francois, H. ;

Lazarovici, J. ;

Le Pavec, J. ;

De Martin, E. ;

Mateus, C. ;

Michot, J. -M. ;

Samuel, D. ;

Soria, J. -C. ;

Robert, C. ;

Eggermont, A. ;

Marabelle, A. .

ANNALS OF ONCOLOGY, 2016, 27 (04) :559-574

[10] Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical Trial [J].

Cleeland, Charles S. ;

Wang, Xin Shelley ;

Shi, Qiuling ;

Mendoza, Tito R. ;

Wright, Sherry L. ;

Berry, Madonna D. ;

Malveaux, Donna ;

Shah, Pankil K. ;

Gning, Ibrahima ;

Hofstetter, Wayne L. ;

Putnam, Joe B., Jr. ;

Vaporciyan, Ara A. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (08) :994-1000

← 1 2 3 4 5 →